MR [Mindray Medical International] 20-F: (Original Filing)

[INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 28 ITEM 4A. UNRESOLVED STAFF COMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 76 ITEM 7.] [LIST OF SUBSIDIARIES • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Shenzhen Mindray Investment & Development Co., Ltd. , incorporated in the People’s Republic of China • Shenzhen Mindray Software Technology Co., Ltd. , incorporated in the People’s Republic of China • Nanjing Mindray Bio-Medical Electronics Co., Ltd. , incorporated in the People’s] [MINDRAY MEDICAL INTERNATIONAL LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Code of Business Conduct and Ethics Contents I. Statement of Mission, Vision and Pillars II. Principle on Compliance of Law III. Principle on Conflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure and Confidentiality VI. Principle on Honesty and Fair Trading VII. Principle on Protection of] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Director, President and Chief Executive Officer Alex Lung Chief Financial Officer EX-13.1 6 d463253dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 8, 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY

[INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 28 ITEM 4A. UNRESOLVED STAFF COMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 76 ITEM 7.] [LIST OF SUBSIDIARIES • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Shenzhen Mindray Investment & Development Co., Ltd. , incorporated in the People’s Republic of China • Shenzhen Mindray Software Technology Co., Ltd. , incorporated in the People’s Republic of China • Nanjing Mindray Bio-Medical Electronics Co., Ltd. , incorporated in the People’s] [MINDRAY MEDICAL INTERNATIONAL LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Code of Business Conduct and Ethics Contents I. Statement of Mission, Vision and Pillars II. Principle on Compliance of Law III. Principle on Conflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure and Confidentiality VI. Principle on Honesty and Fair Trading VII. Principle on Protection of] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Director, President and Chief Executive Officer Alex Lung Chief Financial Officer EX-13.1 6 d463253dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 8, 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 20-F: (Original Filing)

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF STYLE="font-family:Times New Roman" SIZE="2"> BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2"> I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; STYLE="font-family:Times New Roman" SIZE="2">2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF STYLE="font-family:Times New Roman" SIZE="2"> BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2"> I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; STYLE="font-family:Times New Roman" SIZE="2">2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality VI. Principle on Honesty and Fair Trading] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to the reference to us]

EFUT [eFuture] 6-K: FORM 6-K EFUTURE INFORMATION TECHNOLOGY INC. 8/F TopNew

[FORM 6-K EFUTURE INFORMATION TECHNOLOGY INC. 8/F TopNew Tower 2 15 Guanghua Road Chaoyang District Beijing 100026, People's Republic of China 86-10-51650988 Form 20-F [ X ] Form 40-F [ ] Yes [ ] No [ X ] EFUTURE INFORMATION TECHNOLOGY INC.]

By | 2016-04-01T04:56:29+00:00 April 8th, 2013|Categories: Chinese Stocks, EFUT, Webplus ver|Tags: , , , , , |0 Comments

SPU [SkyPeople Fruit Juice] 8-K: Investment agreement in Mei County Kiwi Comprehensive Deep

[Investment agreement in Mei County Kiwi Comprehensive Deep Processing Zone Party A Party A: Managing Committee of Mei County National Kiwi Fruit Wholesale Trading Center (Party A has been authorized by the People’s Government of Mei County to be in charge of the construction and administration of the Mei County National Kiwi Fruit Wholesale Trading Center) (hereinafter referred to as] [For more information, please contact: COMPANY Xin Ma, Chief Financial Officer SkyPeople Fruit Juice, Inc. Tel: China + 86 - 29-8837-7161 oliver.x.ma@skypeoplefruitjuice . com Email: http://www.skypeoplefruitjuice.com Web: INVESTOR RELATIONS David Rudnick, Account Manager CCG Investor Relations Tel: US +1- 646-626-4172 david.rudnick@ccgi r .com Email: http://www.ccgir.com Web: SkyPeople Fruit Juice Announces Agreement to Manufacture and Market Kiwi Products SPU News XI’AN,] [CURRENT REPORT FORM 8-K Date of report (Date of earliest event reported): April 3, 2013 001-34502 SkyPeople Fruit Juice, Inc. (Exact name of small business issuer as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) 98-0222013 (IRS Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi'an, China 710075 86-29-88377161 Not]

GIGM [GIGAMEDIA] 6-K: (Original Filing)

[For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia to Report Fourth-Quarter and Full-Year 2012 Financial Results on April 11 TAIPEI, Taiwan, April 3, 2013 – GigaMedia Limited (NASDAQ: GIGM) announced today that it will report its fourth-quarter and full-year 2012 financial results on Thursday, April 11, 2013 after the market closes. Management] [For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Teams Up with Atos to Strengthen Cloud Business and Accelerate Growth; Launches GigaCloud Strategic cooperation with Atos, a global leader in technology services, brings world-class quality and security to GigaCloud’s existing SME solutions; will help promote product and develop new offerings TAIPEI, Taiwan, April]

GIGM [GIGAMEDIA] 6-K: For further information contact: Brad Miller, Investor Relations

[For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia to Report Fourth-Quarter and Full-Year 2012 Financial Results on April 11 TAIPEI, Taiwan, April 3, 2013 – GigaMedia Limited (NASDAQ: GIGM) announced today that it will report its fourth-quarter and full-year 2012 financial results on Thursday, April 11, 2013 after the market closes. Management] [For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Teams Up with Atos to Strengthen Cloud Business and Accelerate Growth; Launches GigaCloud Strategic cooperation with Atos, a global leader in technology services, brings world-class quality and security to GigaCloud’s existing SME solutions; will help promote product and develop new offerings TAIPEI, Taiwan, April]

Skip to toolbar